Newsroom

CSRxP Statement on Novartis’ $475,000 Price Tag for Kymriah

“While we are very excited about the potential for CAR-T therapies to save lives, Novartis’ pricing decision disappointingly pushes an unsustainable trend even closer to the breaking point.”

Read more

CSRxP Calls for Action on CREATES Act

CSRxP Calls for Action on CREATES Act The Campaign for Sustainable Rx Pricing released this statement from spokesman Will Holley on today’s House Judiciary Subcommittee on […]

Read more

CSRxP Calls for Further Action on Rx Prices

CSRxP spokesman Will Holley releases statement following House passage of FDA user fee legislation.

Read more

CSRxP Releases Powerful Testimonial: “Debbie’s Story”

CSRxP Releases Powerful Testimonial: “Debbie’s Story”   The Campaign for Sustainable Rx Pricing has released a powerful testimonial from Debbie, a Georgia resident, whose prescription drug bill […]

Read more